BIOTRICITY INC.
corporate_fare Company Profile
BIOTRICITY INC. (OTC:BTCY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 9 items for BTCY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 7/10. Across its 9 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for BTCY spans 10-Q, 10-K, DEF 14C, PRE 14C.
Recent high-impact activity:
- Biotricity Q2 Revenue Climbs 11.5% as Gross Margin Widens to 83.3%
- Biotricity Q1 FY2027: Revenue Climbs 10%, Yet Going Concern and Series C Exchange Loom
- Biotricity Posts First Operating Profit, Revenue Jumps 16% to $16M
- Biotricity 10-K: Going Concern Warning Despite Operating Turnaround; 1-for-100 Reverse Split Pending
- Biotricity Confirms Aggressive 1-for-100 Reverse Stock Split
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 118,661 shares in BTCY as of the October 30, 2026 settlement, a 0.3% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 69.8% of BTCY volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.